CD19-ReTARG(TPR): A Novel Fusion Protein for Physiological Engagement of Anti-CMV Cytotoxic T Cells Against CD19-Expressing Malignancies.
CD19-ReTARG(TPR)：一种新型融合蛋白，可使抗CMV细胞毒性T细胞生理性地对抗表达CD19的恶性肿瘤
期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17142300
van Wijngaarden Anne Paulien, Britsch Isabel, Peipp Matthias, Samplonius Douwe Freerk, Helfrich Wijnand
